32results about How to "Control weight gain" patented technology

A nutritional supplement composition having therapeutically effective amounts of milk minerals including calcium, a protein source including κ-casein fragment 106-169, and enzyme-inhibiting peptides is provided for the treatment of body weight conditions. The nutritional supplement composition is administered in amounts effective for limiting weight gain and / or enhancing weight loss, as well as promoting overall good health, in the treatment of body weight conditions, including overweight and obesity.

The invention discloses a preparation method and an application of pu-erh tea extractive with a blood fat reducing function. The preparation method comprises the following steps in sequence of: adding water to the pu-erh tea to leach; filtering the extracting liquid; absorbing by macroporous resin; eluting by ethanol-water solution; concentrating the leaching liquid until reaching a certain proportion; and drying the concentrate, thus obtaining the pu-erh tea extractive. According to the preparation method, the characteristic of high effective component content of the pu-erh tea extractive is utilized to prepare the tea drinks, tea bags, pu-erh cream and tea beverage which have the effects of obviously controlling the raise of the weight, reducing the liver index, fat index and LEE'S index, raising high-density lipoprotein cholesterol and reducing triglyceride.

The present invention relates to a composition comprising phentermine and a selective 5HT-2C receptor agonist. In addition, the invention relates to a composition comprising phentermine and a selective 5HT-2C receptor agonist having Formula (I):or a pharmaceutically acceptable salt, solvate or hydrate thereof. These compositions are useful in pharmaceutical compositions whose use includes the treatment of obesity.

The present invention relates to certain 1-substituted-2,3,4,5-tetrahydro-3-benzazepine derivatives of Formula (I), that are modulators of the 5HT2C receptor. Accordingly, compounds of the present invention are useful for the prophylaxis or treatment of 5HT2C receptor associated diseases, conditions or disorders, such as, obesity and related disorders.

The invention provides methods for treating diabetes or obesity, as well as methods for inducing weight loss, preventing weight gain, or controlling weight in a patient in need thereof. The methods comprise administering to the patient at least one effective dose of a GLP-1 receptor agonist, or a regimen of GLP-1 receptor agonist comprising a plurality of substantially evenly spaced doses. The effective dose or regimen does not induce substantial nausea or appetite suppression in the patient.

The invention relates to a composition capable of helping control body weight and a preparation method thereof. The composition capable of helping control body weight consists of the following ingredients: 400-500 parts of enzyme-hydrolyzed oat flour, 100-300 parts of milk and milk products, 50-150 parts of plant fat powder, 10-30 parts of medium-chain triglyceride powder, 10-90 parts of soybean protein, 5-30 parts of fruit and vegetable powder, 35-105 parts of resistant dextrin, 10-100 parts of oat bran powder, 10 100-parts of konjac powder, 5-60 parts of a white kidney bean extract, 5-60 parts of collagen pepetides, 3-30 parts of a fiber extract, 5-50 parts of bamboo shoot fiber, 5-15 parts of trehalose, 5-50 parts of rice protein, and 2-20 parts of vitamins and minerals. The compositioncapable of helping control body weight prepared by the preparation method is comprehensive in nutrients, better in weight reduction effects, and capable of effectively controlling body weight.

The invention discloses a Rhodiola L. and the application of the extract thereof as the drug for preventing and curing the impaired glucose tolerance / diabetes, adiposis and the relative metabolic diseases; meanwhile, the invention discloses a preparation method for the extract; in addition, the invention further discloses the application of a pharmaceutical composition including the Rhodiola L. and the Rhodiola L. extract, and particularly discloses the application of the pharmaceutical composition used for preparing the drugs and the health-care products for curing and preventing the impaired glucose tolerance / diabetes, adiposis and the relative metabolic diseases.

A nutritional supplement composition having a therapeutically effective amount of peptides is provided for the treatment of body weight conditions. The nutritional supplement may also comprise milk minerals, such as calcium and / or be combined with a protein source including κ-casein fragment 106-169. The nutritional supplement composition is administered in amounts effective for limiting weight gain and / or enhancing weight loss, as well as promoting overall good health, in the treatment of body weight conditions, including overweight and obesity. In one embodiment, the supplement is administered through a calorically restricted diet.

The invention relates to the technical field of medicines and specifically relates to a preparation method of an andrographolide enteric dry suspension. A specific technical solution is that the preparation method of the andrographolide enteric dry suspension specifically includes: dissolving hydroxypropyl cellulose, and then, adding sodium dodecyl sulfate to prepare a solvent containing 3%-5% ofsolids as a binder; next, sieving andrographolide, lactose and microcrystalline cellulose, then, adding the sieved andrographolide, lactose and microcrystalline cellulose into a high-speed centrifugalpelletizing and coating machine, forming particles, and then, drying the particles; and coating the dried particles with isolating layers and enteric layers in the coating machine, and finally, mixing the particles with a suspending agent and a corrigent to finally prepare the andrographolide enteric dry suspension. By using the preparation method, the problem that an existing andrographolide dispersible tablet is extremely easy to degrade in gastric juice is solved.

The invention belongs to the technical field of air vehicle stealth, and particularly relates to a cavity structure using a wave-absorbing material. The cavity structure uses metal or a carbon fiber composite as a base, different positions of the interior of a cavity of the cavity structure are coated with different thicknesses or different types of wave-absorbing materials, through the wave-absorbing material application scheme designed through the design method, the wave-absorbing performance of a wave-absorbing material used for an air inlet channel can be effectively improved, and the potential of existing materials is achieved better; and the using zone of the wave-absorbing material is reduced, using of wide-frequency-band wave-absorbing materials is reduced, accordingly, the cost and difficulty of the wave-absorbing material scheme are decreased, and air inlet channel forward radar stealth is achieved with high efficiency and low cost.

The invention relates to application of a mulberry extract in preparation of drugs for reducing body weight of an animal. The mulberry extract is characterized by containing alkaloids, polysaccharides, amino acids and flavones; and preferably, the mulberry extract contains the ingredients in weight content: 3%-99% of alkaloids, 0.2%-70% of polysaccharides, 0%-10% of flavones, 0%-50% of amino acids and 0%-25% of other ingredients. The mulberry extract disclosed by the invention can be used for controlling type 2 diabetes accompanying ponderal growth and has a good treatment effect on type 2 diabetes merged obesity.

The present invention relates to a composition comprising phentermine and a selective 5HT-2C receptor agonist. In addition, the invention relates to a composition comprising phentermine and a selective 5HT-2C receptor agonist having Formula (I): or a pharmaceutically acceptable salt, solvate or hydrate thereof. These compositions are useful in pharmaceutical compositions whose use includes the treatment of obesity.

Compositions, foods, and beverages which contain a salt-free or a reduced-salt fermented soybean paste-like food material in which the salt content is 5% or less, obtained by hydrolyzing soybean by a koji mold have an excellent anti-obesity action.

The invention relates to application of a traditional Chinese medicine composition in preparation of a medicine for preventing and / or treating myocardial ischemia reperfusion injury. The traditional Chinese medicine composition is prepared from radix rehmanniae praeparata, rhizoma coptidis, radix paeoniae alba, radix scutellariae, colla corii asini and poria. The traditional Chinese medicine composition can obviously control the weight gain of a rat after ovariectomy and can obviously reduce the infarction area of the rat under myocardial ischemia-reperfusion injury after ovariectomy; the levels of serum LDH and serum CK after myocardial ischemia reperfusion are remarkably reduced, and myocardial damage is reduced; and according to the application, the expression of GRP78 protein, CHOP protein, Active-caspase12 protein and the Active-caspase3 protein after the myocardial ischemia reperfusion can be significantly inhibited and reduced, so as to inhibit the apoptosis of the myocardial cells after the myocardial ischemia reperfusion.

The invention relates to the technical field of medicines, and in particular relates to a preparation method of an andrographolide enteric-coated tablet. The specific technical scheme is as follows: the method for preparing the andrographolide enteric-coated tablet comprises the following steps: adding an adhesive, andrographolide, lactose and microcrystalline cellulose into a high-speed mixing wet-process granulating device to perform mixing and granulating; then adding the prepared medicine particles into a boiling dryer for drying, wherein the water content is controlled to be 2-5%; granulating the dried medicine particles by using a granulating machine, and finally performing tabletting by using a high-speed rotary tabletting machine to obtain a tablet core of the andrographolide enteric-coated tablet; and coating the tablet core of the enteric-coated tablet with an isolation layer and an enteric-coated layer. The invention solves the problem that the prior andrographolide dispersible tablets are degraded easily in gastric juice.

The invention relates to a home management method and system for hemodialysis patients based on an informatization technology. The method is characterized in that 1) a management system comprising a patient end, a medical care end and a server is arranged, and the medical care end is wirelessly connected with the patient end through the server or directly connected with the patient end to form a two-way communication loop; 2) the patient end carries out weight measurement reminding, blood pressure measurement reminding, water drinking reminding and medicine taking reminding at regular time so as to enable a patient to carry out weight measurement, blood pressure measurement, quantitative water drinking and quantitative medicine taking at regular time, and if the weight, the blood pressure and the water intake of the patient exceed limits, an alarm is given out; and 3) the medical care terminal monitors the body weight, blood pressure, water intake and medicine taking of the patient and performs health propaganda and education to guide the patient to control the body weight, measure the blood pressure, control the water intake and a medicine taking amount, and the medical care terminal transmits propaganda and education videos or documents to the patient terminal to supervise and urge the patient to conduct learning, observe the learning progress and perform examination reminding. The method and the device have the outstanding substantial characteristic and remarkable progress of capability of monitoring the body weight condition, the water drinking condition and the blood pressure control condition of the patient.

The invention discloses a preparation method for plant effective nutrient elements. The plant effective nutrient elements are effective nutrient elements reserved in plants after carbohydrate in the natural plants which can be digested and absorbed by human bodies is removed. The preparation flow is that plant fruits are selected and are peeled; solution color protection, pulping, extraction and filtration are conducted to obtain filtrate A; enzymolysis is conducted to solids obtained after extraction; secondary filtration is conducted, the obtained filtrate is discarded, and secondary enzymolysis is conducted to the obtained filtered cake after complex enzyme is added; after enzymolysis, tertiary filtration is conducted to obtain filtrate B; the filtrate B is combined with the filtrate A and the obtained mixed filtrate is lyophilized at low temperature; and screening and packaging are conducted. The content of resistant starch in effective ingredients of the plant effective nutrient elements is more than 80 percent. The plant effective nutrient elements have the efficacies of reducing blood glucose value and insulin response after dinner, relieving diabetes, reducing the pH value in the intestinal tract, preventing colorectal cancers, improving constipation conditions; proliferating beneficial bacteria, inhibiting pernicious bacteria, enhancing lipid metabolism, maintaining cardiovascular health, controlling body weight increase, increasing mineral absorption and the like.

The invention belong to the field of health products and discloses composition ingredients and a preparation method of a health soft capsule which takes VE (Vitamin E) and curcumin as main drug ingredients and has a certain effect. Main drug ingredients comprise 7.5-85% of curcumin extract, 10-85% of curcumin and 1.5-7.5% of VE, and a soft capsule auxiliary material approved by pharmacy is added to prepare the soft capsule. The health soft capsule is readily available in raw materials, low in production cost, safe to eat, convenient to store, carry and take and does not have toxic or side effect.

The invention provides methods for treating diabetes or obesity, as well as methods for inducing weight loss, preventing weight gain, or controlling weight in a patient in need thereof. The methods comprise administering to the patient at least one effective dose of a GLP-1 receptor agonist, or a regimen of GLP-1 receptor agonist comprising a plurality of substantially evenly spaced doses. The effective dose or regimen does not induce substantial nausea or appetite suppression in the patient.

The invention discloses a sugar-free hard candy and a making method thereof. The sugar-free hard candy comprises the following components in parts by weight: 20-100 parts of sugar alcohol, 1-9 parts of a white kidney bean extract, 1-15 parts of camphor tree seed kernel oil, 0.2-1.5 parts of an acidulant and 0.02-0.05 part of a sweetening agent. Through cooperative use of the white kidney bean extract and the camphor tree seed kernel oil, on one hand, the camphor tree seed kernel oil is high in metabolism speed, and fat deposition in the body is reduced; on the other hand, the white kidney bean extract hinders or delays hydrolysis and digestion of main carbohydrates in food by the human body and reduces decomposition and absorption of starch carbohydrates in the food, and the white kidney bean extract and the camphor tree seed kernel oil have a synergistic effect, so that the effect of losing weight is achieved.

A connecting structure for connecting an actuator to an opening flap for opening and closing an exterior trim component of a motor vehicle is disclosed, wherein the connecting structure has at least one carrier arrangement, which can be connected to the opening flap, and at least one connecting section arranged on the carrier arrangement, with which the opening flap can be connected to the actuator for moving the opening flap. The invention also relates to an exterior trim component with such a connecting structure and to a motor vehicle with such an exterior trim component.

The invention relates to a tablet containing sacubitril valsartan sodium and a preparation method of the tablet. The sacubitril valsartan sodium tablet or tablet core is prepared from the following components in parts by weight: 40-60 parts of sacubitril valsartan sodium, 5-25 parts of xylitol, 20-50 parts of silicified microcrystalline cellulose, 1-5 parts of a disintegrating agent and 0.25-0.75 part of a lubricating agent, wherein the particle size D90 of the silicified microcrystalline cellulose is 65-125 microns, and the mass ratio of the xylitol to the silicified microcrystalline cellulose is (1.5-4.5) : 1. According to the tablet provided by the invention, xylitol and silicified microcrystalline cellulose are used as filling agents, specific auxiliary materials are screened out, and the ratio of the auxiliary materials is controlled. The formula solves the sticking problem of the tablet in the preparation process. The medicine has the advantages of simple preparation method, low cost, quick dissolution, good friability, smooth and stickless tablet surface, good stability and the like. The method is suitable for large-scale industrial production.

The invention discloses an enzyme for preventing obesity and regulating intestinal flora as well as a preparation method and application of the enzyme. The enzyme is prepared by fermenting the following raw materials in parts by weight: 20-40 parts of aloe fermentation stock solution, 40-60 parts of comprehensive fruit and vegetable fermentation stock solution, 1-15 parts of fructo-oligosaccharide, 1-15 parts of galactooligosaccharide and 1-10 parts of trehalose. The enzyme can significantly reduce the body weight growth rate, epididymal fat and perirenal fat weight, can also increase the richness of intestinal flora, and is beneficial to the proliferation of beneficial bacteria and the inhibition of harmful bacteria.

The invention relates to the technical field of medicine, in particular to a preparation method of andrographolide enteric-coated dry suspension. The specific technical scheme is: a preparation method of andrographolide enteric-coated dry suspension, specifically: adding sodium lauryl sulfate after dissolving hydroxypropyl cellulose to prepare a solvent with a solid content of 3% to 5% as a solvent Adhesive, and then sieve andrographolide, lactose and microcrystalline cellulose and add to the high-speed centrifugal granulation coating machine, and then dry after the granules are formed; in the coating machine, isolate the dried granules layer and enteric-coated layer, and finally mixed with suspending agent and flavoring agent to finally prepare andrographolide enteric-coated dry suspension. The invention solves the problem that the existing andrographolide dispersible tablets are easily degraded in gastric juice.

The present application provides a novel phenyl derivative, 5-[(2,4-dinitrophenoxy)methyl]-1-methyl-2-nitro-1H-imidazole or a pharmaceutically acceptable salt thereof, which is useful for regulating mitochondria activity, reducing adiposity, treating diseases including diabetes and diabetes-associated complications.

The invention discloses a probiotic solid beverage with a fat-reducing function. The probiotic solid beverage comprises the following components in parts by weight: 5-10 parts of Bifidobacterium lactis B420 freeze-dried powder, 15-25 parts of polydextrose, 5-15 parts of fructo-oligosaccharide, 3-6 parts of trehalose, 0.01-0.03 part of sorbitol, 1-2 parts of ascorbic acid, 0.1-0.3 part of black fungus polysaccharide, 0.1-0.3 part of flaxseed gum and 0.3-0.6 part of calcium silicate. The probiotic solid beverage can promote intestinal health, prevent overnutrition-type obesity, and is high in product stability and significant in fat reduction effect.